Cymarin
| Clinical data | |
|---|---|
| ATC code | |
| Identifiers | |
| CAS Number | |
| PubChem CID | |
| E number | {{#property:P628}} |
| ECHA InfoCard | {{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value). |
| Chemical and physical data | |
| Formula | C30H44O9 |
| Molar mass | 548.665 g/mol |
|
WikiDoc Resources for Cymarin |
|
Articles |
|---|
|
Most recent articles on Cymarin |
|
Media |
|
Evidence Based Medicine |
|
Clinical Trials |
|
Ongoing Trials on Cymarin at Clinical Trials.gov Clinical Trials on Cymarin at Google
|
|
Guidelines / Policies / Govt |
|
US National Guidelines Clearinghouse on Cymarin
|
|
Books |
|
News |
|
Commentary |
|
Definitions |
|
Patient Resources / Community |
|
Directions to Hospitals Treating Cymarin Risk calculators and risk factors for Cymarin
|
|
Healthcare Provider Resources |
|
Causes & Risk Factors for Cymarin |
|
Continuing Medical Education (CME) |
|
International |
|
|
|
Business |
|
Experimental / Informatics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Cymarin (or cymarine) is a cardiac glycoside. Apocynum cannabinum used as a source of fiber by Native Americans and Apocynum venetum used as a herbal tea in China both contain cymarin.[1] Cymarin is a cardiac glycoside and an anti-arrhythmia and cardiotonic agent.[2]
References
- ↑ Edible and Medicinal plants of the West, Gregory L. Tilford, ISBN 0-87842-359-1
- ↑ http://pubchem.ncbi.nlm.nih.gov/summary/summary.cgi?cid=539061#x94
- Pages with script errors
- E number from Wikidata
- ECHA InfoCard ID from Wikidata
- Infobox drug articles without a structure image
- Articles without EBI source
- Chemical pages without ChemSpiderID
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Articles without InChI source
- Articles without UNII source
- Drugs with no legal status
- Articles containing unverified chemical infoboxes
- Cardiac glycosides
- Cardiovascular Drugs
- Drug